Hosted By
Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, Anna talks about what we know so far and her experience with clients taking these drugs in clinical practice.
Website: http://annamarsh.co.uk/
Instagram: https://www.instagram.com/anna_marsh_nutrition/
Research Paper: https://www.sciencedirect.com/science/article/abs/pii/S0002962925011061
Take the Fatigue Recovery Quiz: https://app.annamarsh.co.uk/quiz
New Nurturing Resilience Membership: https://annamarsh.co.uk/nurturing-resilience/
This is a guest expert interview with Zoe McKenzie where we discuss her book which has recently been published. Although the book title suggests...
Supplement sensitivity can be common in the Chronic Illness and Chronic Fatigue community. After recently posting on instagram on the topic of supplement sensitivity,...
In Chronic Fatigue Recovery, healing happens from a regulated place and yet our nervous system state also influences how we approach healing. This creates...
